Company Number: 13249733

Analysis Date: 2025-07-20 13:32 UTC

Financial Health Assessment of ZENAUTH LTD (as at 31 Dec 2024)

---

1. Financial Health Score: B

Explanation:
ZENAUTH LTD demonstrates generally strong financial health with robust net assets and healthy liquidity, but there are warning signs in declining fixed asset values and accumulated losses that prevent an A grade. The company maintains solid working capital and cash reserves, essential "vital signs" of financial wellness, yet the profit and loss reserve signals ongoing operational challenges.

---

2. Key Vital Signs

Metric	2024 Figure	Interpretation
Net Assets	£3.74 million	Positive and substantial net assets indicate a solid equity base.
Shareholders' Funds	£3.74 million	Equity backing remains strong but has decreased from previous years.
Cash & Cash Equivalents	£1.23 million	Healthy cash flow "heartbeat" ensuring operational liquidity and short-term obligations.
Current Assets	£1.23 million	Adequate short-term resources to cover current liabilities.
Current Liabilities	£31,755	Low short-term liabilities relative to assets — low financial stress risk.
Net Current Assets (Working Capital)	£1.19 million	A very positive working capital indicating good short-term financial health.
Fixed Assets	£2.54 million	Declining fixed asset base compared to prior years; may suggest asset disposals or impairments.
Profit & Loss Reserve	(£5.12 million)	Accumulated losses indicate ongoing operational deficits or investment expenses.
Investments	£2.53 million	Investments form a significant portion of fixed assets, but decreased notably from 2023.
Average Employees	6	Small team size consistent with micro/small company profile in software publishing.

---

3. Diagnosis: What the Financial Data Reveals

• Liquidity & Working Capital:
  The company exhibits a "healthy pulse" with strong cash reserves (£1.23m) and net current assets (£1.19m), meaning it can comfortably meet its short-term obligations. This is a positive symptom reflecting good cash management and operational liquidity.

• Asset Base & Investment:
  Fixed assets have decreased by ~33% from £3.83m in 2023 to £2.54m in 2024, mainly due to disposals of investments (£1.29m disposed). This could reflect strategic portfolio adjustments or asset sales to raise cash, which may be a prudent measure but also signals potential contraction or shift in business assets.

• Accumulated Losses:
  The large negative profit and loss reserve (£5.12m) is a "chronic symptom" indicating that the company has accumulated operational losses or heavy expenses over time. While shareholders' equity remains positive (due to share premium), continual losses need addressing for long-term sustainability.

• Shareholders’ Funds:
  Equity has decreased from £5.45m in 2023 to £3.74m in 2024, reflecting the impact of operational losses and asset disposals. This reduction suggests some financial strain but not yet critical distress.

• Size & Scale:
  With only 6 employees and operating in the niche SIC code 58290 (Other software publishing), the company is a small, focused entity likely investing heavily in software development or intellectual property.

• Governance & Control:
  Directors and significant control are held by two individuals each owning 25-50%, indicating stable ownership structure but potential concentration risk.

---

4. Recommendations: Steps to Improve Financial Wellness

• Address Operational Losses:
  Investigate the causes of the accumulated loss reserve. Implement cost controls, review pricing strategies, and enhance revenue streams to move towards profitability. Profitability is the "heart" of financial health; without it, sustainability weakens.

• Asset Management Strategy:
  Review the investment portfolio and fixed asset utilization. Ensure disposals are strategic and not forced by liquidity needs. Consider reinvesting in productive assets or R&D to drive future growth.

• Cash Flow Monitoring:
  Maintain strong cash reserves and monitor cash flow closely to avoid liquidity shocks. Establish rolling cash flow forecasts as a diagnostic tool to anticipate issues early.

• Strengthen Equity Base:
  If losses persist, consider capital injections or equity fundraising to bolster shareholders' funds and provide a buffer against future downturns.

• Operational Efficiency:
  With a small team, maximize productivity and possibly outsource non-core functions to keep costs lean.

• Financial Reporting & Planning:
  Continue clear, timely financial reporting to directors and stakeholders. Develop strategic financial plans with scenario analysis to improve resilience.

---

Medical Analogy Summary:

ZENAUTH LTD’s financial “vital signs” like liquidity and working capital are strong, indicating a stable short-term condition. However, the “symptom” of accumulated losses and declining fixed assets suggests a risk of “chronic illness” that could impair long-term vitality. Immediate attention to profitability and asset strategy will be akin to proactive treatment preserving the company’s financial health.

---